141 related articles for article (PubMed ID: 6653652)
1. Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.
Carlsen JE; Kardel T; Jensen HA; Tangø M; Trap-Jensen J
Eur J Clin Pharmacol; 1983; 25(4):557-61. PubMed ID: 6653652
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
Bareggi SR; Gambaro V; Valenti M; Benvenuti C
Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
[TBL] [Abstract][Full Text] [Related]
3. Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.
D'Arcy V; Laher M; McCoy D; Sullivan P; Walsh CH; Hickey MP
Eur J Clin Pharmacol; 1985; 28(3):347-9. PubMed ID: 4007040
[TBL] [Abstract][Full Text] [Related]
4. N"-Cyano-N-4-pyridyl-N'-1,2,2-trimethyl-propylguanidine, a new vasodilating agent: acute effect of blood pressure and pharmacokinetics in hypertensive patients.
Kardel T; Hilden T; Carlsen J; Trap-Jensen J
J Cardiovasc Pharmacol; 1981; 3(5):1002-7. PubMed ID: 6168845
[TBL] [Abstract][Full Text] [Related]
5. Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.
Breen EG; Mulhall D; Keogh JA
Eur J Clin Pharmacol; 1985; 28(4):381-6. PubMed ID: 4029244
[TBL] [Abstract][Full Text] [Related]
6. Pinacidil monotherapy for hypertension.
Ward JW
Br J Clin Pharmacol; 1984 Aug; 18(2):223-5. PubMed ID: 6487460
[TBL] [Abstract][Full Text] [Related]
7. The antihypertensive effect of pinacidil versus prazosin in mild to moderate hypertensive patients seen in general practice.
Sterndorff B; Johansen P
Acta Med Scand; 1988; 224(4):329-36. PubMed ID: 3188983
[TBL] [Abstract][Full Text] [Related]
8. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.
Ward JW; McBurney A; Farrow PR; Sharp P
Eur J Clin Pharmacol; 1984; 26(5):603-8. PubMed ID: 6468476
[TBL] [Abstract][Full Text] [Related]
10. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
Goldberg MR; Offen WW
Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evaluation of pinacidil in hypertension.
Ramsay LE; Freestone S
Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schirger A; Fisher LD; Shub C; Collins JB; Spiekerman RE
Eur J Clin Pharmacol; 1986; 31(2):133-41. PubMed ID: 3803413
[TBL] [Abstract][Full Text] [Related]
13. Intravenous pinacidil in the acute treatment of hypertension.
Rijk MC; Thien T
J Clin Pharmacol; 1987 Jul; 27(7):468-74. PubMed ID: 3308975
[TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
[TBL] [Abstract][Full Text] [Related]
15. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Friedel HA; Brogden RN
Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin.
Goldberg MR; Sushak CS; Rockhold FW; Thompson WL
Clin Pharmacol Ther; 1988 Jul; 44(1):78-92. PubMed ID: 3292105
[TBL] [Abstract][Full Text] [Related]
17. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
Muiesan G; Fariello R; Muiesan ML; Christensen OE
Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
Byyny RL; Nies AS; LoVerde ME; Mitchell WD
Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
[TBL] [Abstract][Full Text] [Related]
20. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
Fletcher AE; Battersby C; Adnitt P; Underwood N; Jurgensen HJ; Bulpitt CJ
J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
